Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

48 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Re: 'Availability of drugs and resistance testing for BPaLM regimen for rifampicin-resistant tuberculosis in Europe' by Lange et al.
Friesen I, Saluzzo F, Groenheit R, Aubry A, Anthony R, Niemann S, Mathys V, Cirillo DM; TB European Reference Laboratory Network (ERLTB-Net-3). Friesen I, et al. Among authors: groenheit r. Clin Microbiol Infect. 2024 Sep;30(9):1204-1206. doi: 10.1016/j.cmi.2024.06.001. Epub 2024 Jun 6. Clin Microbiol Infect. 2024. PMID: 38851424 No abstract available.
Loss-of-function mutations in ndh do not confer delamanid, ethionamide, isoniazid, or pretomanid resistance in Mycobacterium tuberculosis.
Pandey S, Vilchèze C, Werngren J, Bainomugisa A, Mansjö M, Groenheit R, Miotto P, Cirillo DM, Coulter C, Baulard AR, Schön T, Jacobs WR Jr, Djaout K, Köser CU. Pandey S, et al. Among authors: groenheit r. Antimicrob Agents Chemother. 2024 Jan 10;68(1):e0109623. doi: 10.1128/aac.01096-23. Epub 2023 Dec 1. Antimicrob Agents Chemother. 2024. PMID: 38038476 Free PMC article.
Bedaquiline and clofazimine resistance in Mycobacterium tuberculosis: an in-vitro and in-silico data analysis.
Sonnenkalb L, Carter JJ, Spitaleri A, Iqbal Z, Hunt M, Malone KM, Utpatel C, Cirillo DM, Rodrigues C, Nilgiriwala KS, Fowler PW, Merker M, Niemann S; Comprehensive Resistance Prediction for Tuberculosis: an International Consortium. Sonnenkalb L, et al. Lancet Microbe. 2023 May;4(5):e358-e368. doi: 10.1016/S2666-5247(23)00002-2. Epub 2023 Mar 29. Lancet Microbe. 2023. PMID: 37003285 Free PMC article.
Appeal from the European tuberculosis reference laboratory network (ERLTB-Net) for improving the diagnosis of infections due to nontuberculous mycobacteria.
Tagliani E, Kohl TA, Ghodousi A, Groenheit R, Holicka Y, Niemann S, Maurer FP, Cirillo DM, Cambau E. Tagliani E, et al. Among authors: groenheit r. Clin Microbiol Infect. 2024 Jan;30(1):4-6. doi: 10.1016/j.cmi.2023.06.005. Epub 2023 Jun 14. Clin Microbiol Infect. 2024. PMID: 37321396 Free article. No abstract available.
Extensively drug-resistant tuberculosis, Pakistan.
Hasan R, Jabeen K, Ali A, Rafiq Y, Laiq R, Malik B, Tanveer M, Groenheit R, Ghebremichael S, Hoffner S, Hasan Z. Hasan R, et al. Among authors: groenheit r. Emerg Infect Dis. 2010 Sep;16(9):1473-5. doi: 10.3201/eid1609.100280. Emerg Infect Dis. 2010. PMID: 20735937 Free PMC article.
48 results